Securing single-use systems: SSB opts for blockbuster resins and supplier partnerships
Single-use vendors must address their own supply chains to help overcome end-user challenges, says Sartorius.
Single-use vendors must address their own supply chains to help overcome end-user challenges, says Sartorius.
Takeda has begun construction of an Irish facility to support production of its orally delivered blood cancer peptide Ninlaro (ixazomib).
Hitachi Group subsidiary PCT Cell Therapy Services will provide clinical manufacturing services for Orchard’s autologous gene therapy for the treatment of adenosine deaminase deficiency.